| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.42 | 0.01 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.43 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |